Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-16

Clinical Trial Update: Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS [NA]

View source ↗

Summary

A clinical trial is assessing whether ketosis affects the signs and symptoms of schizophrenia and bipolar-related disorders, with recruitment ongoing at AMC-UvA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Schizophrenia and Related Disorders, Psychosis | NA | Status: RECRUITING